Haemonetics Corporation (HAE)
Interest coverage
| Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | — | 168,361 | 156,033 | 80,750 | 57,963 |
| Interest expense | US$ in thousands | 9,746 | 13,018 | 14,630 | 17,121 | 16,834 |
| Interest coverage | 0.00 | 12.93 | 10.67 | 4.72 | 3.44 |
March 31, 2025 calculation
Interest coverage = EBIT ÷ Interest expense
= $—K ÷ $9,746K
= 0.00
Haemonetics Corporation's interest coverage has shown an improving trend over the past five years. In March 2021, the interest coverage ratio stood at 3.44, indicating the company generated 3.44 times the earnings necessary to cover its interest expenses. By March 2025, however, the interest coverage ratio dropped to 0.00, suggesting the company was unable to cover its interest expenses with its earnings during that period. It's crucial for Haemonetics Corporation to closely monitor its interest coverage ratio and take necessary actions to ensure it remains at a healthy level to meet its financial obligations and maintain investor confidence.
Peer comparison
Mar 31, 2025